Novo Nordisk's Awiqli Receives FDA Approval As The First And Only Once-Weekly Insulin For Children 10 Years Of Age And Older With Type 2 Diabetes

뉴스 본문을 불러오고 있어요.

Novo Nordisk's Awiqli Receives FDA Approval As The First And Only Once-Weekly Insulin For Children 10 Years Of Age And Older With Type 2 Diabetes | 웨이프 WAPE

Novo Nordisk's Awiqli Receives FDA Approval As The First And Only Once-Weekly Insulin For Children 10 Years Of Age And Older With Type 2 Diabetes

기사 요약

관련 종목

댓글 —